A proteomic landscape of pharmacologic perturbations for functional relevance
Open Access
- 31 August 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 14 (1) , 128-139
Abstract
No abstract availableKeywords
Funding Information
- China Association for Science and Technology (2022QNRC001)
- National Key Research and Development Program of China Stem Cell and Translational Research (2020YFE0202200)
- National Natural Science Foundation of China (22225702, 32322048)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2021276)
- National Key Research and Development Program of China
- Program of Shanghai Academic Research Leader (22XD1420900)
- Shanghai Rising-Star Program (22QA1411100)
This publication has 59 references indexed in Scilit:
- Proteomic Signatures of Acquired Letrozole Resistance in Breast Cancer: Suppressed Estrogen Signaling and Increased Cell Motility and InvasivenessMolecular & Cellular Proteomics, 2013
- Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian CancerJournal of Proteome Research, 2012
- Quantitative Proteomic Analysis Revealed Lovastatin-induced Perturbation of Cellular Pathways in HL-60 CellsJournal of Proteome Research, 2011
- Tackling the widespread and critical impact of batch effects in high-throughput dataNature Reviews Genetics, 2010
- Identification of a Primary Target of Thalidomide TeratogenicityScience, 2010
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Adjusting batch effects in microarray expression data using empirical Bayes methodsBiostatistics, 2006
- Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cellsBiochemical Pharmacology, 2005
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003